but our chief africa correspondent jennifer zabasajja has been looking into this for us, what are we bout these various infection patterns? jennifer: it seems public health officials are learning new things about the way that this virus is spreading. and really finding that there's a lot of different ways that we are seeing transmission happening. if we just talk about what we are seeing more globally first, we are seeing sporadic cases popping up across the world and experts believe that we may continue to see that happening just given the way this mutated virus is spreading. if we zero in on the drc, because those are the pictures we are looking at now, what we have seen in the past is that there is an older strain that has been spilling from a humans. but perhaps the good thing is we aren't seeing as much airborne transition happening. there is concern about children on the impact on children and it appears at least on the ground at the drc again, 80% of child cases has been a subvariant called clay one a. the concern is this clade one beta variant that is expected to be a bit more

jennifer zabasajja has the latest. where are we on the spread of the mpox strain? r: this is the first known case of this mutated strain that's actually said to be known in asia, but it's important to keep track of what these different mutated strains are because in 2022 we saw a separate outbreak happening, a clade ii variant. the concern is this mutated strain of this clade one variant, called clade 1-b. it's important to remember because it is said to be increasing in transmission and potentially even more fatal so that is the concern and that's why we are seeing more countries like thailand and singapore and china and india and countries stepping up testing and surveillance but testing still where it is endemic in parts of africa is still quite low, so that's why we are hearing them talk a lot about testing, and on the vaccine front on thursday we heard from bavarian nordic, which does have one of the only improved -- only approved mpox vaccines in the u.s. and europe, and they said they have the capacity to produce at least 2 million doses by the end of the yea

jennifer zabasajja joins me for more.e us an update on what we have learned from authorities yesterday. >> you were just pointing to some comments we did get from the africa cdc on tuesday. we did hear from the who, which is trying to dispel concerns that what we're seeing from mpox whether it is a new or old strain, is anything like what we saw with covid and instead trying to stress that we need to avoid the panic before and instead be proactive. you mentioned proactive vaccine distribution which we did hear the africa cdc director talking about how important it is to get africans vaccinated and for that to then help for global health emergency. health officials spending tuesday focusing at least on educating the public on that front. lizzy: which vaccine manufacturers will provide those jabs? >> we have heard a lot of interest from vaccine manufacturers wanting to be part of this global flight. when it comes to testing capabilities, we heard from roche saying they want to update their laboratories to support mpox testi